NAPPI® Circulars

MediKredit distributes circulars to the healthcare industry to notify stakeholders of any important information or changes relating to NAPPI® codes.

ReferenceSubjectEffective Date
N004/2021

Notification of NAPPI Code for Covishield COVID-19 Vaccine

04/02/2021 Download
N003/2021

Notification of Section 21 Product Changed to Registered Product –Roche Products

03/02/2021 Download
N002/2021

Notification of NAPPI Code Changes for Syrspend

27/01/2021 Download
N001/2021

Notification of Change in Number of Uses – Medtronic Africa

11/01/2021 Download
N019/2020

NAPPI Notification of Change in Number of Uses - Implantcast

28/12/2020 Download
N018/2020

NAPPI Notification of Change in Number of Uses – Medtronic Africa

23/12/2020 Download
N017/2020

NAPPI Change from Section 21 Product to SAHPRA Registered Product – Darzalex Solution

01/12/2020 Download
N016/2020

NAPPI Change from Section 21 product to Registered product – Equity Pharmaceuticals

25/11/2020 Download
N015/2020

NAPPI Notification of Change in Number of Uses – Supra Healthcare

16/11/2020 Download
N014/2020

NAPPI Change from Section 21 product to SAHPRA Registered product – Venclexta - Abbvie

08/10/2020 Download
N013/2020

NAPPI Notification of Change in Number of Uses – Envision Africa

07/10/2020 Download
N012/2020

Notification of Section 21 Product Changed to Registered Product - Imnovid

14/08/2020 Download
N011/2020

NAPPI Code and Pack Size Change – Zimmer Biomet

04/08/2020 Download
N010/2020

Notification of Change in Number of Uses - Werkomed

30/06/2020 Download
N009/2020

NAPPI Notification of Change in Number of Uses – Q Surgical

02/06/2020 Download
N008/2020

Notification of Sectio 21 Product Changed to Registered - Repatha

25/04/2020 Download
N007/2020

Notification of Section 21 Product Changed to Registered & Pack size Change - Axim e-z paque

12/03/2020 Download
N006/2020

Notification of Section 21 Product Change to Registered Product – Ingelheim Pharmaceuticals

05/03/2020 Download
N005/2020

Notification of Important NAPPI Code Changes (Nerlynx & Odystra)

04/03/2020 Download
N004/2020

Notification of Section 21 Product Change to Registered Product - Stelara

13/02/2020 Download
N003/2020

NAPPI Notification of Change in Number of Uses - SilvoCure

06/02/2020 Download
N002/2020

Notification of Change in number of uses Vertice Healthcare

04/02/2020 Download
N001/2020

Notification of Section 21 Product Change to Registered Product - Kadcyla

10/01/2020 Download
N031/2019

NAPPI Notification of Change in Number of Uses – Lanoy Medical

02/12/2019 Download
N030/2019

Notification of Voluntary Withdrawal of Product – Ultak Tablets

11/10/2019 Download
N029/2019

Notification of Voluntary Withdrawal of Product – Gulf Ranitidine Tablets

29/10/2019 Download
N028/2019

Notification of Product Recall – Ranitidine Biotech Tablets

06/11/2019 Download
N027/2019

NAPPI Notification of Product Recall - Zantac

17/10/2019 Download
N026/2019

NAPPI Notification of Section 21 Product Changed to registered Product – Tafinlar 75mg - Novartis

15/10/2019 Download
N025/2019

NAPPI Notification of Change in Number of Uses – BMK Orthopaedics

11/10/2019 Download